High dose rate brachytherapy as monotherapy for localised prostate cancer

To evaluate the oncological outcome of a three-implant high dose rate (HDR) brachytherapy (BRT) protocol as monotherapy for clinically localised prostate cancer.

http://ift.tt/2xjkuJs